EveryAILaw.com

Article 7 treats healthcare AI as support in prevention, diagnosis, care, and therapeutic choice while reserving the clinical decision to medical professionals. It separately gives the interested person a right to be informed of AI use and requires healthcare AI systems and their data to be reliable, periodically verified, and updated. Penalties qualification: This entry does not assign a provision-specific penalty to the Article 7 requirements. Applicable oversight and sanctions depend on the competent authority and the relevant national and EU framework. Institutional context (not a private requirement): Article 10 inserts Article 12-bis into Decree-Law 179/2012. It assigns AGENAS the design, implementation, operation, and ownership of a national healthcare AI platform. The platform supplies non-binding suggestions to healthcare professionals and doctors and access support to users. These are statutory functions of AGENAS and the platform, not requirements imposed on the private deployers described in the Article 7 provision above.

Article 11 requires employers and principals to inform workers of workplace AI use in the cases and modalities of Article 1-bis of Legislative Decree 152/1997. That incorporated provision covers fully automated decision or monitoring systems producing indications relevant to specified employment decisions and conditions. Article 4(4) separately ties under-14 access to AI technologies and consequent personal-data processing to parental-responsibility consent. Penalties qualification: This entry does not assign a provision-specific penalty to Article 11. Applicable consequences depend on the incorporated employment-law duties and the competent national and EU enforcement frameworks.

Penalties qualification: This entry does not assign a provision-specific penalty to Article 11. Applicable consequences depend on the competent employment, data-protection, national AI, and EU enforcement frameworks.

Article 8 establishes a health-research pathway for specified public, nonprofit, IRCCS, and participating private health-sector actors. For those actors and purposes, secondary use under paragraph 2 is limited to personal data lacking direct identifiers, preserves the information duty, and carries an exception where identity is unavoidable or necessary to protect health. Processing under paragraphs 1 and 2 must be communicated to the Garante and may begin after 30 days if the Garante has not blocked it. Penalties qualification: Article 8(6) preserves the Garante's inspection, prohibition, and sanctioning powers. This entry does not assign a fixed penalty ceiling or infringement category to Article 8 conduct. Institutional context (not a private requirement): Article 8(4) permits AGENAS, after consulting the Garante and considering international standards and the state of the art, to establish and update guidelines for anonymization procedures and synthetic data. The provision grants an institutional power; it does not itself impose a universal anonymization standard on every researcher.